Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 27, 2023. (Total: 221476Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Diabetes Mellitus and APOL1[original query]
Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
American journal of nephrology 2011 34 (5): 452-9.
Behar Doron M, Kedem Eynat, Rosset Saharon, Haileselassie Yonas, Tzur Shay, Kra-Oz Zipi, Wasser Walter G, Shenhar Yotam, Shahar Eduardo, Hassoun Gamal, Maor Carcom, Wolday Dawit, Pollack Shimon, Skorecki Ka
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
Kidney international 2015 Jan 87 (1): 176-81.
Freedman Barry I, Langefeld Carl D, Lu Lingyi, Palmer Nicholette D, Smith S Carrie, Bagwell Benjamin M, Hicks Pamela J, Xu Jianzhao, Wagenknecht Lynne E, Raffield Laura M, Register Thomas C, Carr J Jeffrey, Bowden Donald W, Divers Jasm
Association between MYH9 and APOL1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes in a Chinese Han Population.
Journal of diabetes research 2018 2018 5068578.
Zhao Hailing, Ma Liang, Yan Meihua, Wang Yan, Zhao Tingting, Zhang Haojun, Liu Peng, Liu Yanzhen, Li Pi
APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults.
Circulation. Genomic and precision medicine 2018 Jun 11 (6): e002098.
Gutiérrez Orlando M, Irvin Marguerite R, Chaudhary Ninad S, Cushman Mary, Zakai Neil A, David Victor A, Limou Sophie, Pamir Nathalie, Reiner Alex P, Naik Rakhi P, Sale Michele M, Safford Monika M, Hyacinth Hyacinth I, Judd Suzanne E, Kopp Jeffrey B, Winkler Cheryl
Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
Trials 2019 6 20 (1): 341.
Aliyu Muktar H, Wudil Usman J, Ingles Donna J, Shepherd Bryan E, Gong Wu, Musa Baba M, Muhammad Hamza, Sani Mahmoud U, Abdu Aliyu, Nalado Aisha M, Atanda Akinfenwa, Ahonkhai Aima A, Ikizler Talat A, Winkler Cheryl A, Kopp Jeffrey B, Kimmel Paul L, Wester C Willi
Association between polymorphism rs2032487 in the non-muscle myosin heavy chain IIA gene (MHY9) and chronic kidney disease secondary to type 2 diabetes mellitus in a population of the Canary Islands.
Endocrinologia, diabetes y nutricion 2019 Apr .
Boronat Mauro, Tugores Antonio, Saavedra Pedro, Garay Paloma, Bosch Elvira, Lorenzo Dionisio, García-Cantón Cés
Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
Cardiorenal medicine 2019 Apr 9 (4): 212-221.
Lertdumrongluk Paungpaga, Streja Elani, Rhee Connie M, Moradi Hamid, Chang Yongen, Reddy Uttam, Tantisattamo Ekamol, Kalantar-Zadeh Kamyar, Kopp Jeffrey
TOP